- Home
- SILO vs ALLR Comparison
SILO vs ALLR Comparison
Compare SILO & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- ALLR
- Stock Information
- Founded
- SILO 2010
- ALLR 2004
- Country
- SILO United States
- ALLR United States
- Employees
- SILO N/A
- ALLR N/A
- Industry
- SILO Apparel
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- SILO Consumer Discretionary
- ALLR Health Care
- Exchange
- SILO Nasdaq
- ALLR Nasdaq
- Market Cap
- SILO 4.7M
- ALLR 4.7M
- IPO Year
- SILO N/A
- ALLR N/A
- Fundamental
- Price
- SILO $1.96
- ALLR $1.05
- Analyst Decision
- SILO
- ALLR
- Analyst Count
- SILO 0
- ALLR 0
- Target Price
- SILO N/A
- ALLR N/A
- AVG Volume (30 Days)
- SILO 9.0M
- ALLR 2.6M
- Earning Date
- SILO 02-14-2025
- ALLR 03-07-2025
- Dividend Yield
- SILO N/A
- ALLR N/A
- EPS Growth
- SILO N/A
- ALLR N/A
- EPS
- SILO N/A
- ALLR N/A
- Revenue
- SILO $72,102.00
- ALLR N/A
- Revenue This Year
- SILO $1.86
- ALLR N/A
- Revenue Next Year
- SILO N/A
- ALLR N/A
- P/E Ratio
- SILO N/A
- ALLR N/A
- Revenue Growth
- SILO N/A
- ALLR N/A
- 52 Week Low
- SILO $0.77
- ALLR $0.90
- 52 Week High
- SILO $4.50
- ALLR $288.00
- Technical
- Relative Strength Index (RSI)
- SILO 79.84
- ALLR 47.15
- Support Level
- SILO $1.62
- ALLR $0.96
- Resistance Level
- SILO $2.16
- ALLR $1.72
- Average True Range (ATR)
- SILO 0.31
- ALLR 0.17
- MACD
- SILO 0.10
- ALLR 0.01
- Stochastic Oscillator
- SILO 43.37
- ALLR 13.99
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.